We are live on ! Find out more
PAVMZ

PAVmed Inc. Series Z Warrant
PAVMZ

Delisted

PAVMZ was delisted on the 30th of April, 2025.

Back to rankings

6 hedge funds and large institutions have $737K invested in PAVmed Inc. Series Z Warrant in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

33% less funds holding

Funds holding: 9 → 6 (-3)

45% less capital invested

Capital invested by funds: $1.34M → $737K (-$601K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
6
Holders Change
-3
Holders Change %
-33.33%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LCS
Levin Capital Strategies
New York
+$11.9K
2
WAM
Wolverine Asset Management
Illinois
+$6.77K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$386K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$19K
3
VF
Virtu Financial
New York
-$14K

PAVMZ Hedge Fund Activity: Q3 2020 in Review

6 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q3 2020, worth a combined $737K — down 45% from $1.34M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PAVMZ and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Levin Capital Strategies, adding an estimated $11.9K. The largest seller was Sabby Management, cutting an estimated $386K.

  • 6 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q3 2020, down from 9 in Q2 2020.
  • Funds reported $737K of PAVmed Inc. Series Z Warrant stock for Q3 2020, down 45% quarter-over-quarter.
  • 0 funds opened new PAVmed Inc. Series Z Warrant positions in Q3 2020 and 3 closed out, a net change of -3 holders.
  • The largest PAVmed Inc. Series Z Warrant buyer in Q3 2020 was Levin Capital Strategies, an estimated $11.9K added.
  • The largest PAVmed Inc. Series Z Warrant seller in Q3 2020 was Sabby Management, an estimated $386K sold.

Based on aggregated 13F filings for Q3 2020.